S100A12 and pediatric acute respiratory distress syndrome: Additionally, we identified a non-significant trend towards increased concentrations of Resistin (p = 0.054) and S100A12 (p = 0.15) as well as decreased concentrations of Interferon alpha (p = 0.15) in patients with moderate to severe pARDS compared to patients with no or mild pARDS.